top of page
ARVO 2026: ANTERIOR SEGMENT / GLAUCOMA SHOWCASE
Moderators: Julie Schallhorn, MD, MS and Kuldev Singh, MD
Room: 401
Start | Company | Presenter |
|---|---|---|
1:30 PM | Introduction | Robert L. Avery, MD |
1:31 PM | BioLattice Ophthalmics Inc | Linda Alunkal, MBA, CEO & Co-Founder |
1:36 PM | Cloudbreak Pharma, Inc | Francis S. Mah, MD, Director, Cornea & Co-Director,Refractive Surgery at Scripps Clinic Medical Group |
1:41 PM | Discussion | |
1:44 PM | ECI Therapeutics | Elan Weiner, CEO |
1:49 PM | Emmecell | Ramin Valian, CEO |
1:54 PM | Discussion | |
1:57 PM | iVeena | Bala Ambati MD, PhD, MBA, Founder & Chief Medical Officer |
2:02 PM | IVIEW Therapeutics, Inc | Bo Liang, PhD, MBA, Chairman & CEO |
2:07 PM | Discussion | |
2:10 PM | OKYO Pharma | Robert J. Dempsey, MBA, CEO |
2:15 PM | Precise Bio | Aryeh Batt, CEO &Co-Founder |
2:20 PM | Discussion | |
2:23 PM | Stuart Therapeutics | Eric Schlumpf, President & CEO |
2:28 PM | Theialife | Thomas Ruggia, President & CEO |
2:33 PM | VivaVision Biotech | Albert Tsai, MD, MBA, Chief Medical Officer |
2:38 PM | Discussion | |
2:42 PM | Enlighten Clinical Solutions | Jim Harris, Founder & CEO |
2:47 PM | machineMD | Avantika Naidu, PhD, VP, Business Development |
2:52 PM | Conclusion | Kuldev Singh, MD |
2:57 PM | End of Session |
Anchor 1
bottom of page